UBS Maintains Buy on AnaptysBio, Raises Price Target to $76
AnaptysBio, Inc.
AnaptysBio, Inc. ANAB | 0.00 |
UBS analyst Michael Yee maintains AnaptysBio (NASDAQ:
ANAB) with a Buy and raises the price target from $60 to $76.
UBS Maintains Buy on AnaptysBio, Raises Price Target to $76
AnaptysBio, Inc. ANAB | 0.00 |